Morus alba , a Medicinal Plant for Appetite Suppression and Weight Loss
Authors:
- 10 July 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Medicinal Food
- Vol. 22 (7) , 741-751
Abstract
The prevalence of obesity is expanding rapidly worldwide, making the disease a global burden with limited treatment options. The current obesity drug development trends suggest the possibility of reducing weight and reverse metabolic disturbances of obesity by controlling appetite. In this study, we screened more than 8000 plants from our plant library for the cannabinoid (CB 1 ) receptor antagonists and identified Morus alba as a lead medicinal plant. Kuwanon G and Albanin G were isolated and identified from root-barks of Morus alba with 92% and 96% CB 1 receptor ligand binding inhibitory activity, respectively. The bioflavonoid standardized extract was tested in the acute food intake study in rats at oral doses of 250 and 500 mg/kg for its appetite suppression activity. Diet-induced obesity in the C57BL/6J mice was used to evaluate the long-term food intake reduction activity and effect on the weight loss administered orally at 250 and 500 mg/kg for 7 weeks. Statistically significant and dose-dependent reduction in food intake was observed in both acute and long-term studies for the extract. Food intake reductions of 58.6% and 44.8% at 250 mg/kg and 50.1% and 44.3% at 500 mg/kg were observed at 1 and 2 h postfood provision, respectively. A 20% reduction in daily calorie intake was observed in the long-term study. Obese mice treated with the high dose of Morus root-bark extract showed 10.4 g (22.5%) and 7.1 g (16.5%) loss in body weight compared with the vehicle-treated obese animals (at week 7) and baseline, respectively. Statistically significant reductions in biochemical markers and visceral fat deposit were also observed. These results demonstrated that Morus alba extracts enriched in Kuwanon G, and Albanin G could be used alone to control appetite, manage body weight, and improve metabolic syndromes.Keywords
This publication has 35 references indexed in Scilit:
- Comparison of Inhibitory Activities and Mechanisms of Five Mulberry Plant Bioactive Components against α-GlucosidaseJournal of Agricultural and Food Chemistry, 2013
- Combined Treatment of Mulberry Leaf and Fruit Extract Ameliorates Obesity-Related Inflammation and Oxidative Stress in High Fat Diet-Induced Obese MiceJournal of Medicinal Food, 2013
- Antidiabetic and Antioxidant Effects and Phytochemicals of Mulberry Fruit (Morus alba L.) Polyphenol Enhanced ExtractPLOS ONE, 2013
- Bioactivation Pathways of the Cannabinoid Receptor 1 Antagonist RimonabantDrug Metabolism and Disposition, 2011
- Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adipose tissue in db/db miceAtherosclerosis, 2009
- Discovery and Structure−Activity Relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT2C Receptor Agonist for the Treatment of ObesityJournal of Medicinal Chemistry, 2007
- Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed ratsLife Sciences, 2006
- Endogenous cannabinoid system as a modulator of food intakeInternational Journal of Obesity, 2003
- Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the ratBritish Journal of Pharmacology, 1997
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993